BackAlzamend Neuro Overview

Alzamend Neuro Receivables

Latest receivables for ALZN: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average / median

Loading

Alzamend Neuro Receivables History

Loading

Alzamend Neuro vs. peers: Receivables Comparison

Loading

Alzamend Neuro Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alzamend Neuro (ALZN) FAQ

As of the most recent data (April 2026), ALZN shows a receivables of $0. Scroll down for historical charts and peer comparison views.

Tracking ALZN's receivables over time shows whether Alzamend Neuro is scaling, shrinking, or reshaping that part of the business. The current reading is $0 Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Alzamend Neuro's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Alzamend Neuro's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.